Current treatments for chronic kidney disease (CKD) only delay disease progression and can be associated with significant side effects. Here, Suzstak and Breyer discuss emerging novel targets and strategies for the treatment of CKD. Key challenges faced in the development of CKD therapies and future clinical trial designs are considered.
- Matthew D. Breyer
- Katalin Susztak
